- Home
- TCBK vs OCS Comparison
TCBK vs OCS Comparison
Compare TCBK & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBK | OCS |
|---|---|---|
| Founded | 1975 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TCBK | OCS |
|---|---|---|
| Price | $50.05 | $27.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $48.60 | $39.57 |
| AVG Volume (30 Days) | 107.0K | ★ 209.9K |
| Earning Date | 01-22-2026 | 03-10-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ 6.94 | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | ★ $407,118,000.00 | $991,999.00 |
| Revenue This Year | $9.49 | $14.53 |
| Revenue Next Year | $5.50 | $691.13 |
| P/E Ratio | $13.92 | ★ N/A |
| Revenue Growth | ★ 4.61 | N/A |
| 52 Week Low | $35.20 | $14.00 |
| 52 Week High | $52.05 | $27.00 |
Technical Indicators
Market Signals| Indicator | TCBK | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 84.66 |
| Support Level | $48.49 | $22.60 |
| Resistance Level | $52.05 | $24.50 |
| Average True Range (ATR) | 1.39 | 1.34 |
| MACD | 0.21 | 0.52 |
| Stochastic Oscillator | 63.83 | 96.72 |
Price Performance
Historical ComparisonAbout TCBK TriCo Bancshares
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.